Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (322)

« Back to Publications

Belantamab Mafodotin Triggers Immune Invigoration in Multiple Myeloma Via Inflammatory and Immunogenic Cell Death

Watson ECR. et al, (2025)

systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.

Wang C-Y. et al, (2025), Commun Med (Lond), 5

ltered hormone and bioactive lipid plasma profile in rodent models of polycystic ovarian syndrome revealed by targeted mass spectrometry

Scott HC. et al, (2025), Journal of Clinical Endocrinology and Metabolism, 15, 1 - 14

Investigation of the mechanisms of sonodynamic therapy

Singh K. and Oppermann U., (2024)

ltered hormone and bioactive lipid plasma profile in rodent models of polycystic ovarian syndrome revealed by targeted mass spectrometry

Scott HC. et al, (2024)

Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.

Van Oekelen O. et al, (2024), Cell Rep Med, 5

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Twumasi C. et al, (2024), Eur J Haematol, 112, 547 - 553

Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing molecules.

Sun J. et al, (2024), Nat Methods, 21, 401 - 405

systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding

Wang C. et al, (2024)

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.

Mouti MA. et al, (2023), Nat Commun, 14

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Kurata K. et al, (2023), Blood Cancer J, 13

Mass cytometry as a tool in target validation and drug discovery.

Watson ECR. et al, (2023), Methods Enzymol, 690, 541 - 574

Long-Read Single-Cell Sequencing Using scCOLOR-seq.

Philpott M. et al, (2023), Methods Mol Biol, 2632, 259 - 267

Phenotypic Chemical Screening in CD4+ T Cells to Identify Epigenetic Inhibitors.

Cribbs AP. and Oppermann U., (2023), Methods Mol Biol, 2706, 225 - 231

Recognition of Dimethylarginine Analogues by Tandem Tudor Domain Protein Spindlin1.

Porzberg MRB. et al, (2022), Molecules, 27

Load More

1
2
3
4
5
6
7
...
»